Skip to main content
SpringerLink
Log in
Book cover

New Psychoactive Substances

Pharmacology, Clinical, Forensic and Analytical Toxicology

  • Book
  • © 2018

Overview

Editors:
  1. Hans H. Maurer

    1. Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Homburg (Saar), Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Simon D. Brandt

    1. School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Gives an update of the multi-layered facets of the “designer drugs” phenomenon that exploded into public’s consciousness in the 2010s
  • Offers diverse perspectives in areas of neuropharmacology, analytical toxicology, epidemiology of adverse events and information-exchange
  • Provides accurate information about psychoactive recreational substances that transcended ‘traditional’ drugs of abuse

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 252)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (18 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures

    • Michael Evans-Brown, Roumen Sedefov
    Pages 3-49

  3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective

    • Justice N. A. Tettey, Conor Crean, Susan C. Ifeagwu, Martin Raithelhuber
    Pages 51-67

  4. Self-Experiments with Psychoactive Substances: A Historical Perspective

    • Torsten Passie, Simon D. Brandt
    Pages 69-110

  5. Neuropharmacology of Synthetic Cathinones

    • Michael H. Baumann, Hailey M. Walters, Marco Niello, Harald H. Sitte
    Pages 113-142

  6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances

    • Linda D. Simmler, Matthias E. Liechti
    Pages 143-164

  7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

    • Samuel D. Banister, Mark Connor
    Pages 165-190

  8. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution

    • Samuel D. Banister, Mark Connor
    Pages 191-226

  9. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action

    • Clinton E. Canal
    Pages 227-260

  10. Phencyclidine-Based New Psychoactive Substances

    • Jason Wallach, Simon D. Brandt
    Pages 261-303

  11. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

    • Jason Wallach, Simon D. Brandt
    Pages 305-352

  12. Synthetic Opioids

    • Patrick M. Beardsley, Yan Zhang
    Pages 353-381

  13. Designer Benzodiazepines: Another Class of New Psychoactive Substances

    • Bjoern Moosmann, Volker Auwärter
    Pages 383-410

  14. Bioanalytical Methods for New Psychoactive Substances

    • Lea Wagmann, Hans H. Maurer
    Pages 413-439

  15. Toxicokinetics of NPS: Update 2017

    • Markus R. Meyer
    Pages 441-459

  16. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project

    • Anders Helander, Matilda Bäckberg
    Pages 461-473

  17. Patterns of Acute Toxicity Associated with New Psychoactive Substances

    • Simon L. Hill, Paul I. Dargan
    Pages 475-494

  18. Fatal Poisonings Associated with New Psychoactive Substances

    • Robert Kronstrand, Davide Guerrieri, Svante Vikingsson, Ariane Wohlfarth, Henrik Gréen
    Pages 495-541

  19. Wastewater Analysis for Community-Wide Drugs Use Assessment

    • Christoph Ort, Lubertus Bijlsma, Sara Castiglioni, Adrian Covaci, Pim de Voogt, Erik Emke et al.
    Pages 543-566
Back to top

Keywords

About this book

This volume is designed to feature the pharmacology of new psychoactive substances, legislative aspects, information exchange including epidemiology, and clinical, forensic, and analytical toxicology in order to facilitate the understanding of this complex and rapidly developing phenomenon.

Editors and Affiliations

  • Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Homburg (Saar), Germany

    Hans H. Maurer

  • School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK

    Simon D. Brandt

Bibliographic Information

  • Book Title: New Psychoactive Substances

  • Book Subtitle: Pharmacology, Clinical, Forensic and Analytical Toxicology

  • Editors: Hans H. Maurer, Simon D. Brandt

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-030-10561-7

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Nature Switzerland AG 2018

  • Hardcover ISBN: 978-3-030-10560-0Published: 06 March 2019

  • eBook ISBN: 978-3-030-10561-7Published: 20 February 2019

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: X, 566

  • Number of Illustrations: 62 b/w illustrations, 28 illustrations in colour

  • Topics: Pharmacology/Toxicology

Publish with us

Policies and ethics

Back to top

Search

Navigation